Overview Financials News + Filings Key Docs Charts Ownership Insiders |
PCT LTD (PCTL)
|
Add to portfolio |
|
|
Price: |
$0.46
| | Metrics |
OS: |
805.6
|
M
| |
|
|
Market cap: |
$371
|
M
| |
|
|
Net debt:
|
$2.45
|
M
| |
|
|
EV:
|
$373
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
|
| |
|
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 |
Revenues | 2.5 | 0.7 | 0.3 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 |
Revenue growth | 255.7% | 166.2% | 116.2% | 8.6% | 80316.3% | | | |
Cost of goods sold | 1.0 | 0.1 | 0.1 | 0.0 | 1.4 | 0.0 | 0.0 | 0.0 |
Gross profit | 1.5 | 0.6 | 0.2 | 0.1 | -1.3 | 0.0 | 0.0 | 0.0 |
Gross margin | 58.5% | 82.6% | 72.4% | 68.1% | -1170.6% | -7115.6% | | |
Selling, general and administrative | 2.5 | 1.9 | 2.5 | 1.8 | | 0.4 | | |
Research and development | 0.0 | 0.0 | 0.0 | 0.3 | 0.1 | 0.0 | | |
General and administrative | 2.5 | 1.9 | 2.5 | 1.7 | 0.8 | 0.4 | 0.0 | 0.0 |
EBITA | -1.1 | -1.3 | -2.7 | -2.0 | -0.9 | -0.5 | 0.0 | 0.0 |
EBITA margin | -43.5% | -185.9% | -1002.5% | -1621.5% | -834.0% | -325982.3% | | |
Amortization of intangibles | 0.3 | 0.3 | | 0.3 | | 0.0 | | |
EBIT | -1.4 | -1.6 | -2.7 | -2.3 | -0.9 | -0.5 | 0.0 | 0.0 |
EBIT margin | -55.6% | -230.0% | -1002.5% | -1843.1% | -834.0% | -343344.7% | | |
Pre-tax income | -3.8 | -16.6 | -3.2 | -2.7 | -2.2 | -0.5 | 0.0 | 0.0 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -4.1 | -16.6 | -3.2 | -2.7 | -2.2 | -0.5 | 0.0 | 0.0 |
Net margin | -162.0% | -2340.3% | -1195.9% | -2210.7% | -1984.0% | -350560.3% | | |
|
Diluted EPS | ($0.01) | ($0.09) | ($0.07) | ($0.07) | ($0.10) | ($0.03) | $0.00 | $0.00 |
Shares outstanding (diluted) | 609.0 | 189.8 | 43.5 | 39.4 | 23.0 | 16.9 | 19.2 | 19.2 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|